How much does Meiyouheng (Becotatug Vedotin for Injection) Cost& price without insurance in China?
Meiyouheng® is the commercial brand name of Becotatug Vedotin for Injection, an antibody-drug conjugate developed by Lepu Biopharma. It targets Nectin-4 antigen on nasopharyngeal carcinoma cells and delivers cytotoxic payload to induce tumor cell death.
Main Indications
Treatment of adult patients with relapsed or metastatic nasopharyngeal carcinoma who have failed at least two prior lines of chemotherapy and anti-PD-1/PD-L1 inhibitor therapy.
Common Side Effects
Common mild adverse reactions: Peripheral neuropathy, fatigue, alopecia, nausea and decreased appetite.
Laboratory abnormalities: Neutropenia and transient liver enzyme elevation.
Severe but manageable risks: Severe myelosuppression, interstitial lung disease and infusion-related hypersensitivity.
Approval Status in China
Meiyouheng® (Becotatug Vedotin for Injection, 50mg per vial) was officially approved for marketing in China in 2025. It is currently a prescription anti-tumor drug included in China’s Category B medical insurance.
Buy Meiyouheng (Becotatug Vedotin for Injection) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
